IVSBF / Investor AB (publ) - SEC备案- 年度报告、委托书

ERIC / Telefonaktiebolaget LM Ericsson (publ) - Depositary Receipt (Common Stock) / INVESTOR AB - SC 13D Activist Investment

SC 13D 1 ef20029485sc13d.htm SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* LM ERICSSON TELEPHONE COMPANY (Translation of registrant’s name into English) (Name of Issuer) Class B Shares (SEK 5.00 nominal value) (Title of Class of Securities) 294821608** (CUSIP Number) Petra Hedengran Managing Di

NDAQ / Nasdaq Inc - 144A / INVESTOR AB - SC 13D/A Activist Investment

SC 13D/A 1 ef20014111sc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-

NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00

NDAQ / Nasdaq Inc / INVESTOR AB - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00

ABB / ABB Ltd. / INVESTOR AB Activist Investment

SC 13D/A 1 formsc13da.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New

ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842

NDAQ / Nasdaq, Inc. / INVESTOR AB - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* NASDAQ, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Petra Hedengran Managing Director and General Counsel Investor AB Arsenalsgatan 8C, SE-103 32 Stockholm, Sweden +46 8 614 20 00

Exhibit 6

EX-99.6 2 ex996.htm EXHIBIT 99.6 EXHIBIT 6 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of Nasdaq, Inc. and further agree that this Joint Filing Agreement shall

ABB / ABB Ltd. / INVESTOR AB Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842

ABB / ABB Ltd. / INVESTOR AB - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 0.12 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842

CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of this Statement) Check the appropriate b

CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - CHINACACHE INTERNATIONAL 13G AMENDMENT NO. 5 Passive Investment

SC 13G/A 1 chinacac13gam5dec2017.htm CHINACACHE INTERNATIONAL 13G AMENDMENT NO. 5 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 31, 20

CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - CHINACACHE INTERNATIONAL HOLDINGS LTD. SC 13G/AM4 Passive Investment

SC 13G/A 1 chinacac13gam4dec2016.htm CHINACACHE INTERNATIONAL HOLDINGS LTD. SC 13G/AM4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M107 (CUSIP Number) December 3

ABB / ABB Ltd. / INVESTOR AB - SCHEDULE 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842

AGRX / Agile Therapeutics, Inc. / INVESTOR AB - AGILE THERAPEUTICS SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Agile Therapeutics, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 00847L100 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 3 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo

ABB / ABB Ltd. / INVESTOR AB - ABB LTD Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3)* ABB Ltd (Name of Issuer) Registered Shares, par value CHF 1.03 (Title of Class of Securities) ISIN CH0012221716 (CUSIP Number) Richard Bernstein, Esq. Lowenstein Sandler LLP 1251 Avenue of the Americas, 17th Floor New York, New York 10020 (646) 414-6842

INVESTOR AB - AMENDMENT NO. 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box

TNGO / Tangoe, Inc. / INVESTOR AB - AMENDMENT NO. 2 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2013 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pur

GWAY / Greenway Medical Technologies Inc / INVESTOR AB - GREENWAY SCHEDULE 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* GREENWAY MEDICAL TECHNOLOGIES, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 39679B 10 3 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to

TNGO / Tangoe, Inc. / INVESTOR AB - CHINA13GAM2DEC12 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b

TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GAM1FEB13 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) Check the appropriate b

MATR / Mattersight Corp. / INVESTOR AB - SC 13D AMENDMENT 1 Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Mattersight Corporation (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 17th Floor New Yo

CCIH / ChinaCache International Holdings Ltd. / INVESTOR AB - AMENDMENT NO. 1 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary Shares, par value $0.0001 per share (Title of Class of Securities) 16950M17 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate bo

TNGO / Tangoe, Inc. / INVESTOR AB - TANGOE13GDEC11 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* TANGOE, INC. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 87582Y108 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* MATTERSIGHT CORPORATION (Name of Issuer) Common Stock, $0.01 par value per share (Title of Class of Securities) 577097108 (CUSIP Number) Anthony O. Pergola, Esq. Richard Bernstein, Esq. Lowenstein Sandler PC 1251 Avenue of the Americas, 18th Floor New Yor

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* THE NASDAQ OMX GROUP, inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2)* THE NASDAQ OMX GROUP, inc. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 3)* ISTA Pharmaceutic

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-l(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No.

Joint Filing Agreement

Exhibit 99.1 Joint Filing Agreement In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the ordinary s

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* ChinaCache International Holdings Ltd. (Name of Issuer) Ordinary shares of par value of $0.0001 per share (Title of Class of Securities) G21191 104 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) Check the appropri

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Cl

Schedule 13G (Amendment No. 3) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3)* ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2010 (Date of Event Which Requires Filing of this Statement) C

STOCK PURCHASE AGREEMENT

EXHIBIT 4 STOCK PURCHASE AGREEMENT This STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of February 7, 2011 by and between each of the sellers named in Schedule I hereto (each, a “Seller,” and, collectively, the “Sellers”), on the one hand, and Investor Trading AB (the “Purchaser”), on the other hand.

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, A

NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 THE NASDAQ OMX GROUP, INC. INVESTOR AB

EXHIBIT 2 EXECUTION VERSION NASDAQ STOCKHOLDERS’ AGREEMENT dated as of December 16, 2010 between THE NASDAQ OMX GROUP, INC.

UNITED STATES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* THE NASDAQ OMX GROUP, INC. (Name of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securities) 631103108 (CUSIP Number) Alan M. Klein, Esq. Simpson Thacher & Bartlett LLP 425 Lexington Avenue New York, NY 10017 (212) 455-2000 (Name, Ad

JOINT FILING AGREEMENT

EXHIBIT 1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the Common Shares of The NASDAQ OMX Group, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of C

Schedule 13G Amendment No. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 31, 2009 (Date of Event Which Requires Filing of this Statement) Ch

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of C

Schedule 13G Amendment No. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 00448Q201 (CUSIP Number) December 18, 2008 (Date of Event Which Requires Filing of this Statement) Ch

As filed with the Securities and Exchange Commission on October 20, 2008 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 For Depositary Shares Evidenced by Ame

As filed with the Securities and Exchange Commission on October 20, 2008 Registration No.

EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730

EXHIBIT 4 Writer’s Direct Dial EMMET, MARVIN & MARTIN, LLP COUNSELLORS AT LAW 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.

THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR COMMON STOCK, NO PAR VALUE, OF INVESTOR AB (INCORPORATED UNDER THE LAWS OF SWEDEN)

AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One-Half of One (1/2) Share) THE BANK OF NEW YORK MELLON AMERICAN DEPOSITARY RECEIPT FOR COMMON STOCK, NO PAR VALUE, OF INVESTOR AB (INCORPORATED UNDER THE LAWS OF SWEDEN) The Bank of New York Mellon, as depositary (hereinafter called the “Depositary”), hereby certifies (i) that there have been deposited with the Depositary o

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title or Clas

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. ) * ACHILLION PHARMACEUTICALS, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title or Class of Securities) 00448Q201 (CUSIP Number) August 12, 2008 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* SCHEDULE 13G SCHEDULE 13G SIGNATURES

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* KYPHON INC. (Name of Issuer) Common Stock, $0.001 par value per share (Title of Class of Securities) 501577100 (CUSIP Number) December 31, 2004 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursua

WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC.

EX-99.B 3 dex99b.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit B THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT,

WARRANT TO PURCHASE COMMON STOCK OF INNOVATIVE MICRO TECHNOLOGY, INC.

EX-99.A 2 dex99a.htm WARRANT TO PURCHASE TO COMMON STOCK Exhibit A THIS WARRANT AND THE SHARES OF COMMON STOCK ISSUABLE UPON ITS EXERCISE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR QUALIFIED UNDER APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, PLEDGED OR OTHERWISE DISPOSED OF UNLESS (i) A REGISTRATION STATEMENT UNDER THE ACT,

Innovative Micro Technology, Inc. INVESTORS’ RIGHTS AGREEMENT Dated as of January 25, 2005 TABLE OF CONTENTS Page ARTICLE I Definitions 1 1.1 Definition of Terms 1 1.2 Construction 4 ARTICLE II Registration Rights 5 2.1 Request for Registration 5 2.2

EX-99.C 4 dex99c.htm INVESTOR'S RIGHTS AGREEMENT Exhibit C Execution Copy Innovative Micro Technology, Inc. INVESTORS’ RIGHTS AGREEMENT Dated as of January 25, 2005 TABLE OF CONTENTS Page ARTICLE I Definitions 1 1.1 Definition of Terms 1 1.2 Construction 4 ARTICLE II Registration Rights 5 2.1 Request for Registration 5 2.2 Registration Incidental to Company Registration 6 2.3 S-3 Registration 6 2.

Innovative Micro Technology, Inc. Voting Agreement

EX-99.D 5 dex99d.htm VOTING AGREEMENT Exhibit D Execution Copy Innovative Micro Technology, Inc. Voting Agreement This Voting Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current Stockholders”) and the investors listed on Schedule I here

Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement

EX-99.E 6 dex99e.htm CO-SALE AGREEMENT Exhibit E Execution Copy Innovative Micro Technology, Inc. Right of First Refusal and Co-Sale Agreement This Right of First Refusal and Co-Sale Agreement (this “Agreement”) is made as of January 25, 2005 by and among Innovative Micro Technology, Inc., a Delaware corporation (the “Company”), the stockholders listed on the signature pages hereto (the “Current S

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovative Micro Technology, Inc. (Name of Issuer) Common Stock, par value $.0001 (Title of Class of Securities) (CUSIP

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Innovative Micro Technology, Inc. (Name of Issuer) Common Stock, par value $.0001 (Title of Class of Securities) 038-213-104 (CUSIP Number) Investor AB Arsenalsgatatan 8C S-103-32 Stockholm Sweden V7 Tel: 46 8 614 21 50 (Name, Address and Telephone Number of Person Aut

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT No. 1 to SCHEDULE 13D Under the Securities Exchange Act of 1934 AstraZeneca PLC (Name of Issuer) CLASS A SHARES (Title of Class of Securities) G9885J102 (CUSIP Number) Fredrik Lindgren Investor AB Arsenalsgatan 8 c S-103 32 Stockholm Sweden 011-46-8-614-2031 (Name, Address and Telephone Number of Person Auth

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KYPHON INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number) December 31, 2002 (Date of Event wh

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 KYPHON INC. (Name of Issuer) Common Stock (Title of Class of Securities) 501577 10 0 (CUSIP Number) December 31, 2002 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: ¨ Rule 13

November , 2002

EX-99.(1)(M) 5 a2094139zex-991m.htm EXHIBIT 99.(1)(M) EXHIBIT 99.(1)(M) November , 2002 ISTA Pharmaceuticals, Inc. 15279 Alton Parkway, Suite 100 Irvine, CA 92618 Re: ISTA Pharmaceuticals, Inc.—Lockup Agreement Ladies and Gentlemen: The undersigned understands that ISTA Pharmaceuticals, Inc., a Delaware corporation (the "Company"), has entered into the Common Stock and Warrant Purchase Agreement,

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Amendment No. 1

QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D/A (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) Amendment No.

JOINT FILING STATEMENT

EX-99.(1)(I) 3 a2094139zex-991i.htm EXHIBIT 99.(1)(I) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(I) JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D/A is filed on behalf of each of us. Dated: November 19, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE EKHO

ISTA PHARMACEUTICALS, INC. AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT

QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.(1)(L) ISTA PHARMACEUTICALS, INC. AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT THIS AMENDMENT TO THE ISTA PHARMACEUTICALS, INC. COMMON STOCK AND WARRANT PURCHASE AGREEMENT (the "Amendment") is made as of November 12, 2002, by and among ISTA Pharmaceuticals, Inc., a Delaware corpo

EXHIBIT C POWER OF ATTORNEY

EX-99.1(C) 5 a2090302zex-991c.htm EXHIBIT 99.1(C) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(c) EXHIBIT C POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR GROWTH CAPITAL LIMITED, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for t

EXHIBIT A JOINT FILING STATEMENT

EX-99.1(A) 3 a2090302zex-991a.htm EXHIBIT 99.1(A) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(a) EXHIBIT A JOINT FILING STATEMENT We, the undersigned, hereby express our agreement that the attached Schedule 13D is filed on behalf of each of us. Dated: September 30, 2002 INVESTOR GROWTH CAPITAL LIMITED /s/ MICHAEL OPORTO Michael Oporto Attorney-in-Fact /s/ BORJE E

EXHIBIT B POWER OF ATTORNEY

EX-99.1(B) 4 a2090302zex-991b.htm EXHIBIT 99.1(B) QuickLinks - Click here to rapidly navigate through this document EXHIBIT 99.1(b) EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned, INVESTOR AB, hereby makes, constitutes and appoints each of BORJE EKHOLM, HENRY GOOSS and MICHAEL OPORTO, acting individually, as its agent and attorney-in-fact for the limited purpose o

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101)

QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No.